A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

Conditions: Bioequivalence Study Interventions: Drug: Sacubitril and Valsartan Tablets 49mg/51mg; Drug: Entresto ® (Sacubitril and Valsartan Tablets 49mg/51mg) Sponsors: Viatris Inc. Not yet recruiting

Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials